Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_assertion type Assertion NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_head.
- NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_assertion description "[The depletion of B cells by anti-CD20/19 monoclonal antibody Retuximab� used in autoimmune diseases therapy leads to systemic side effects and should be significantly improved.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_provenance.
- NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_assertion evidence source_evidence_literature NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_provenance.
- NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_assertion SIO_000772 21677771 NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_provenance.
- NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_assertion wasDerivedFrom befree-20140225 NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_provenance.
- NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_assertion wasGeneratedBy ECO_0000203 NP650964.RAgVyCZnqx4vG941mkTb2bXM2yofbp1LYykjSZLssTE5M130_provenance.